Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950131-97-002181
Filing Date
1997-03-28
Accepted
1997-03-28 00:00:00
Documents
13
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 96234
2 1997 STOCK INCENTIVE PLAN EX-10.8 37785
3 SEPARATION AGREEMENT-RAJESH C. SHROTRIYA EX-10.15 15513
4 TERMINATION AGREEMENT-CHARLES N. BLITZER EX-10.16 23046
5 STOCK PURCHASE & LOAN AGREEMENT-BLITZER EX-10.17 5824
6 SIXTH AMENDMENT TO OFFICE LEASE EX-10.23 4646
7 PROMOTION AGREEMENT EX-10.29 75819
8 COMP. OF NET INCOME (LOSS) PER COMMON SHARE EX-11 1414
9 1996 ANNUAL REPORT TO SHAREHOLDERS EX-13 84376
10 INDEPENDENT AUDITORS CONSENT EX-23 971
11 POWERS OF ATTORNEY EX-24 3102
12 FINANCIAL DATA SCHEDULE EX-27 2378
13 CAUTIONARY STATEMENTS EX-99 20721
  Complete submission text file 0000950131-97-002181.txt   374728
Mailing Address OPUS CENTER 9900 BREN ROAD EAST SUITE 300E MINNEAPOLIS MN 55343
Business Address 9900 BREN RD EAST STE 300E C/O OPUS CENTER MINNETONKA MINNESOTA MINNEAPOLIS MN 55343 6129357335
MGI PHARMA INC (Filer) CIK: 0000702131 (see all company filings)

EIN.: 411364647 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-10736 | Film No.: 97567576
SIC: 2834 Pharmaceutical Preparations